Works by Hiroshi Shibata


Results: 135
    1

    Multicenter retrospective study of initial treatment outcome and feasibility of initiating dose reduction of cabozantinib in unresectable hepatocellular carcinoma.

    Published in:
    Hepatology Research, 2023, v. 53, n. 2, p. 172, doi. 10.1111/hepr.13845
    By:
    • Tomonari, Tetsu;
    • Tani, Joji;
    • Ogawa, Chikara;
    • Deguchi, Akihiro;
    • Senoh, Tomonori;
    • Moriya, Akio;
    • Shibata, Hiroshi;
    • Fukuno, Hiroshi;
    • Tanaka, Hironori;
    • Tanaka, Takahiro;
    • Taniguchi, Tatsuya;
    • Sogabe, Masahiro;
    • Kawano, Yutaka;
    • Morishita, Akihiro;
    • Takaguchi, Koichi;
    • Miyamoto, Hiroshi;
    • Sato, Yasushi;
    • Masaki, Tsutomu;
    • Takayama, Tetsuji
    Publication type:
    Article
    2

    Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.

    Published in:
    Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Hatanaka, Takeshi;
    • Tada, Toshifumi;
    • Kariyama, Kazuya;
    • Tani, Joji;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Kawata, Kazuhito;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori
    Publication type:
    Article
    3

    Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.

    Published in:
    Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
    By:
    • Chuma, Makoto;
    • Uojima, Haruki;
    • Hiraoka, Atsushi;
    • Kobayashi, Satoshi;
    • Toyoda, Hidenori;
    • Tada, Toshifumi;
    • Hidaka, Hisashi;
    • Iwabuchi, Shogo;
    • Numata, Kazushi;
    • Itobayashi, Ei;
    • Itokawa, Norio;
    • Kariyama, Kazuya;
    • Ohama, Hideko;
    • Hattori, Nobuhiro;
    • Hirose, Shunji;
    • Shibata, Hiroshi;
    • Tani, Joji;
    • Imai, Michitaka;
    • Tajiri, Kazuto;
    • Moriya, Satoshi
    Publication type:
    Article
    4
    5

    Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.

    Published in:
    Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya;
    • Itokawa, Norio
    Publication type:
    Article
    6

    Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.

    Published in:
    Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Kariyama, Kazuya;
    • Takaguchi, Koichi;
    • Itobayashi, Ei;
    • Shimada, Noritomo;
    • Tajiri, Kazuto;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Ochi, Hironori;
    • Hirooka, Masashi;
    • Tsutsui, Akemi;
    • Shibata, Hiroshi;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Nouso, Kazuhiro;
    • Joko, Kouji;
    • Hiasa, Yoichi;
    • Michitaka, Kojiro
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Measurement of the nuclear concentration of a-ketoglutarate during adipocyte differentiation by using a fluorescence resonance energy transfer-based biosensor with nuclear localization signals.

    Published in:
    Endocrine Journal, 2021, v. 68, n. 12, p. 1429, doi. 10.1507/endocrj.ej21-0255
    By:
    • Tomohiro Suzuki;
    • Mayuko Hayashi;
    • Tetsuro Komatsu;
    • Akiko Tanioka;
    • Masahiro Nagasawa;
    • Kyoko Tanimura-Inagaki;
    • Rahman, Mohammad Sharifur;
    • Shinnosuke Masuda;
    • Kosuke Yusa;
    • Juro Sakai;
    • Hiroshi Shibata;
    • Takeshi Inagaki
    Publication type:
    Article
    21
    22
    23

    Miglitol prevents diet-induced obesity by stimulating brown adipose tissue and energy expenditure independent of preventing the digestion of carbohydrates.

    Published in:
    Endocrine Journal, 2013, v. 60, n. 10, p. 1117, doi. 10.1507/endocrj.ej13-0333
    By:
    • Tsutomu Sasaki;
    • Mayumi Shimpuku;
    • Tomoya Kitazumi;
    • Haruna Hiraga;
    • Yuko Nakagawa;
    • Hiroshi Shibata;
    • Yuko Okamatsu-Ogura;
    • Osamu Kikuchi;
    • Hye-jin Kim;
    • Yuki Fujita;
    • Jun Maruyama;
    • Vina Yanti Susanti;
    • Hiromi Yokota-Hashimoto;
    • Masaki Kobayashi;
    • Masayuki Saito;
    • Tadahiro Kitamura
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?

    Published in:
    Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
    By:
    • Atsushi Hiraoka;
    • Takashi Kumada;
    • Toshifumi Tada;
    • Kazuya Kariyama;
    • Joji Tani;
    • Shinya Fukunishi;
    • Masanori Atsukawa;
    • Masashi Hirooka;
    • Kunihiko Tsuji;
    • Toru Ishikawa;
    • Koichi Takaguchi;
    • Ei Itobayashi;
    • Kazuto Tajiri;
    • Noritomo Shimada;
    • Hiroshi Shibata;
    • Hironori Ochi;
    • Kazuhito Kawata;
    • Satoshi Yasuda;
    • Hidenori Toyoda;
    • Hideko Ohama
    Publication type:
    Article
    34

    Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 50, doi. 10.1159/000502744
    By:
    • Maeda, Masaki;
    • Saeki, Issei;
    • Sakaida, Isao;
    • Aikata, Hiroshi;
    • Araki, Yasuyuki;
    • Ogawa, Chikara;
    • Kariyama, Kazuya;
    • Nouso, Kazuhiro;
    • Kitamoto, Mikiya;
    • Kobashi, Haruhiko;
    • Sato, Shuichi;
    • Shibata, Hiroshi;
    • Joko, Kouji;
    • Takaki, Shintaro;
    • Takabatake, Hiroyuki;
    • Tsutsui, Akemi;
    • Takaguchi, Koichi;
    • Tomonari, Tetsu;
    • Nakamura, Shinichiro;
    • Nagahara, Takakazu
    Publication type:
    Article
    35

    Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

    Published in:
    Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 73, doi. 10.1159/000503031
    By:
    • Hiraoka, Atsushi;
    • Kumada, Takashi;
    • Fukunishi, Shinya;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Tada, Toshifumi;
    • Toyoda, Hidenori;
    • Yokohama, Keisuke;
    • Nouso, Kazuhiro;
    • Tsutsui, Akemi;
    • Nagano, Takuya
    Publication type:
    Article
    36

    Development of a novel automatic ascites filtration and concentration equipment with multi‐ring‐type roller pump units for cell‐free and concentrated ascites reinfusion therapy.

    Published in:
    Artificial Organs, 2020, v. 44, n. 8, p. 856, doi. 10.1111/aor.13681
    By:
    • Okahisa, Toshiya;
    • Sogabe, Masahiro;
    • Nakagawa, Tadahiko;
    • Tanaka, Kumiko;
    • Tomonari, Tetsu;
    • Taniguchi, Tatsuya;
    • Takahashi, Akira;
    • Kinouchi, Yohsuke;
    • Nishioka, Junji;
    • Igata, Naoki;
    • Yanagawa, Hiroaki;
    • Komatsu, Takatoshi;
    • Ohnishi, Yoshiaki;
    • Fukuhara, Masashi;
    • Ishikawa, Masashi;
    • Shibata, Hiroshi;
    • Shinomiya, Hirohiko;
    • Nakasono, Masahiko;
    • Kishi, Fumiko;
    • Komai, Keiko
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44

    Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.

    Published in:
    Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
    By:
    • Tada, Toshifumi;
    • Kumada, Takashi;
    • Hiraoka, Atsushi;
    • Michitaka, Kojiro;
    • Atsukawa, Masanori;
    • Hirooka, Masashi;
    • Tsuji, Kunihiko;
    • Ishikawa, Toru;
    • Takaguchi, Koichi;
    • Kariyama, Kazuya;
    • Itobayashi, Ei;
    • Tajiri, Kazuto;
    • Shimada, Noritomo;
    • Shibata, Hiroshi;
    • Ochi, Hironori;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Fukunishi, Shinya;
    • Ohama, Hideko;
    • Kawata, Kazuhito
    Publication type:
    Article
    45
    46
    47
    48
    49
    50